SLE pathogenesis is characterized by inflammasome overactivation; one study demonstrated that prolonged IFNα treatment increased inflammasome activity, which was eliminated with knockdown of IRF1 in SLE monocytes (49). This evidence concerns the gene IRF1 and systemic lupus erythematosus.